Donald L. Weaver

28.3k total citations · 12 hit papers
222 papers, 20.3k citations indexed

About

Donald L. Weaver is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Donald L. Weaver has authored 222 papers receiving a total of 20.3k indexed citations (citations by other indexed papers that have themselves been cited), including 113 papers in Oncology, 106 papers in Cancer Research and 69 papers in Pathology and Forensic Medicine. Recurrent topics in Donald L. Weaver's work include Breast Cancer Treatment Studies (94 papers), Breast Lesions and Carcinomas (65 papers) and Global Cancer Incidence and Screening (63 papers). Donald L. Weaver is often cited by papers focused on Breast Cancer Treatment Studies (94 papers), Breast Lesions and Carcinomas (65 papers) and Global Cancer Incidence and Screening (63 papers). Donald L. Weaver collaborates with scholars based in United States, Canada and Türkiye. Donald L. Weaver's co-authors include David N. Krag, Seth P. Harlow, Takamaru Ashikaga, James C. Alex, Jonathan T. Fairbank, Stephen B. Edge, Armando E. Giuliano, Joann G. Elmore, Gary H. Lyman and Thomas B. Julian and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of Clinical Oncology.

In The Last Decade

Donald L. Weaver

220 papers receiving 19.7k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Sentinel Node in Breast Cancer — A Multicenter Validation Study

1998 1.6k citations David N. Krag, Donald L. Weaver et al. profile →
American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer

2005 1.4k citations Gary H. Lyman, Alistair J. Cochran et al. Journal of Clinical Oncology profile →
Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe

1993 1.3k citations David N. Krag, Donald L. Weaver et al. profile →
Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial

2010 1.3k citations David N. Krag, Seth P. Harlow et al. profile →
Revision of the American Joint Committee on Cancer Staging System for Breast Cancer

2002 883 citations Stephen B. Edge, Donald L. Weaver et al. Journal of Clinical Oncology profile →
Prognostic Factors in Breast Cancer

2000 840 citations Donald L. Weaver, James L. Connolly et al. profile →
Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999.

2000 808 citations Donald L. Weaver et al. profile →
Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial

2007 773 citations David N. Krag, Seth P. Harlow et al. profile →
Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

2014 762 citations Gary H. Lyman, Stephen B. Edge et al. Journal of Clinical Oncology profile →
Breast Cancer—Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual

2017 662 citations James L. Connolly, Stephen B. Edge et al. CA A Cancer Journal for Clinicians profile →
Diagnostic Concordance Among Pathologists Interpreting Breast Biopsy Specimens

2015 440 citations Joann G. Elmore, Patricia A. Carney et al. profile →
Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

2017 375 citations Gary H. Lyman, Donald L. Weaver et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Donald L. Weaver

Since Specialization

Citations

This map shows the geographic impact of Donald L. Weaver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donald L. Weaver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donald L. Weaver more than expected).

Fields of papers citing papers by Donald L. Weaver

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donald L. Weaver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donald L. Weaver. The network helps show where Donald L. Weaver may publish in the future.

Co-authorship network of co-authors of Donald L. Weaver

This figure shows the co-authorship network connecting the top 25 collaborators of Donald L. Weaver. A scholar is included among the top collaborators of Donald L. Weaver based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donald L. Weaver. Donald L. Weaver is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Novel Postneoadjuvant Prognostic Breast Cancer Staging System 2025 ·Journal of Clinical Oncology ·David J. Winchester, (unknown), Stephen B. Edge, Kimberly H. Allison, William E. Barlow, Veerle Bossuyt, Mariana Chávez‐MacGregor, Emily F. Conant, James L. Connolly, Jennifer F. De Los Santos, (unknown), (unknown), Elizabeth A. Mittendorf, Jennifer K. Plichta, Elena Provenzano, Kilian Salerno, (unknown), (unknown), Donald L. Weaver, Gabriel N. Hortobágyi, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	3
2	Performance of Supplemental US Screening in Women with Dense Breasts and Varying Breast Cancer Risk: Results from the Breast Cancer Surveillance Consortium 2024 ·Radiology ·Brian L. Sprague, Laura Ichikawa, (unknown), Kathryn P. Lowry, Garth H. Rauscher, Ellen S. O’Meara, Diana L. Miglioretti, Janie M. Lee, Natasha K. Stout, Sally D. Herschorn, Hannah Perry, Donald L. Weaver, Karla Kerlikowske	3
3	Breast cancer risk characteristics of women undergoing whole‐breast ultrasound screening versus mammography alone 2023 ·Cancer ·Brian L. Sprague, Laura Ichikawa, (unknown), Kathryn P. Lowry, Garth H. Rauscher, Ellen S. O’Meara, Diana L. Miglioretti, Shuai Chen, Janie M. Lee, Natasha K. Stout, Jeanne S. Mandelblatt, Nila Alsheik, Sally D. Herschorn, Hannah Perry, Donald L. Weaver, Karla Kerlikowske	6
4	Changes in Mammography Use by Women’s Characteristics During the First 5 Months of the COVID-19 Pandemic 2021 ·JNCI Journal of the National Cancer Institute ·Brian L. Sprague, Kathryn P. Lowry, Diana L. Miglioretti, Nila Alsheik, Erin J. Aiello Bowles, Anna N.A. Tosteson, Garth H. Rauscher, Sally D. Herschorn, Janie M. Lee, Amy Trentham‐Dietz, Donald L. Weaver, Natasha K. Stout, Karla Kerlikowske	62
5	Relationship of Serum Progesterone and Progesterone Metabolites with Mammographic Breast Density and Terminal Ductal Lobular Unit Involution among Women Undergoing Diagnostic Breast Biopsy 2020 ·Journal of Clinical Medicine ·(unknown), Hannah Oh, Shaoqi Fan, Roni T. Falk, Berta M. Geller, Pamela M. Vacek, Donald L. Weaver, John Shepherd, Jeff Wang, Bo Fan, Sally D. Herschorn, Louise A. Brinton, Xia Xu, Mark E. Sherman, Britton Trabert, Gretchen L. Gierach	7
6	Collagen Organization in Relation to Ductal Carcinoma In Situ Pathology and Outcomes 2020 ·Cancer Epidemiology Biomarkers & Prevention ·Brian L. Sprague, Pamela M. Vacek, (unknown), Mark Evans, Amy Trentham‐Dietz, Sally D. Herschorn, Ted A. James, (unknown), Adib Keikhosravi, Kevin W. Eliceiri, Donald L. Weaver, Matthew W. Conklin	29
7	Multicenter Evaluation of Breast Cancer Screening with Digital Breast Tomosynthesis in Combination with Synthetic versus Digital Mammography 2020 ·Radiology ·Samantha P. Zuckerman, Brian L. Sprague, Donald L. Weaver, Sally D. Herschorn, Emily F. Conant	20
8	Deep Feature Representations for Variable-Sized Regions of Interest in Breast Histopathology 2020 ·IEEE Journal of Biomedical and Health Informatics ·(unknown), (unknown), Selim Aksoy, Ezgi Mercan, Linda G. Shapiro, Donald L. Weaver, Joann G. Elmore	7
9	Using Digital Pathology to Understand Epithelial Characteristics of Benign Breast Disease among Women Undergoing Diagnostic Image-Guided Breast Biopsy 2019 ·Cancer Prevention Research ·Maeve Mullooly, (unknown), Shaoqi Fan, Ruth M. Pfeiffer, (unknown), (unknown), Erin L. Kirk, Pamela M. Vacek, Donald L. Weaver, John Shepherd, Amir Pasha Mahmoudzadeh, Jeff Wang, Serghei Malkov, Jason M. Johnson, Stephen M. Hewitt, Sally D. Herschorn, Mark E. Sherman, Melissa A. Troester, Gretchen L. Gierach	1
10	Microarray and RNA in situ hybridization assay for recurrence risk markers of breast carcinoma and ductal carcinoma in situ: Evidence supporting the use of diverse pathways panels 2019 ·Journal of Cellular Biochemistry ·Mark Evans, Pamela M. Vacek, Brian L. Sprague, Gary S. Stein, (unknown), Donald L. Weaver	8
11	Timely follow‐up of positive cancer screening results: A systematic review and recommendations from the PROSPR Consortium 2018 ·CA A Cancer Journal for Clinicians ·Chyke A. Doubeni, Nicole B. Gabler, Cosette M. Wheeler, Anne Marie McCarthy, Philip E. Castle, Ethan A. Halm, Mitchell D. Schnall, Celette Sugg Skinner, Anna N.A. Tosteson, Donald L. Weaver, Anil Vachani, Shivan J. Mehta, Katharine A. Rendle, Stacey A. Fedewa, Douglas A. Corley, Katrina Armstrong	65
12	Complexities of perceived and actual performance in pathology interpretation: A comparison of cutaneous melanocytic skin and breast interpretations 2018 ·Journal of Cutaneous Pathology ·Patricia A. Carney, Frederick A. Spencer, Lisa M. Reisch, Linda Titus, Stevan R. Knezevich, Martin A. Weinstock, Michael W. Piepkorn, Raymond L. Barnhill, David E. Elder, Donald L. Weaver, Joann G. Elmore	2
13	Characterizing Diagnostic Search Patterns in Digital Breast Pathology: Scanners and Drillers 2017 ·Journal of Digital Imaging ·Ezgi Mercan, Linda G. Shapiro, Tad T. Brunyé, Donald L. Weaver, Joann G. Elmore	24
14	Multi-Instance Multi-Label Learning for Multi-Class Classification of Whole Slide Breast Histopathology Images 2017 ·IEEE Transactions on Medical Imaging ·(unknown), Selim Aksoy, Ezgi Mercan, Linda G. Shapiro, Donald L. Weaver, Joann G. Elmore	86
15	Breast cancer screening using tomosynthesis in combination with digital mammography compared to digital mammography alone: a cohort study within the PROSPR consortium 2016 ·Breast Cancer Research and Treatment ·Emily F. Conant, Elisabeth F. Beaber, Brian L. Sprague, Sally D. Herschorn, Donald L. Weaver, Tracy Onega, Anna N.A. Tosteson, Anne Marie McCarthy, Steven P. Poplack, Jennifer S. Haas, Katrina Armstrong, Mitchell D. Schnall, William E. Barlow	146
16	Comparison of Mammographic Density Assessed as Volumes and Areas among Women Undergoing Diagnostic Image-Guided Breast Biopsy 2014 ·Cancer Epidemiology Biomarkers & Prevention ·Gretchen L. Gierach, Berta M. Geller, John Shepherd, Deesha A. Patel, Pamela M. Vacek, Donald L. Weaver, (unknown), Ruth M. Pfeiffer, Bo Fan, Amir Pasha Mahmoudzadeh, Jeff Wang, Jason M. Johnson, Sally D. Herschorn, Louise A. Brinton, Mark E. Sherman	15
17	Sentinel Lymph Node Biopsy for Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Joint Clinical Practice Guideline 2012 ·Journal of Clinical Oncology ·Sandra L. Wong, Charles M. Balch, Patricia A. Hurley, Sanjiv S. Agarwala, Timothy Akhurst, Alistair J. Cochran, Janice N. Cormier, Mark Gorman, (unknown), Kelly M. McMasters, R. Dirk Noyes, Lynn M. Schuchter, Matías E. Valsecchi, Donald L. Weaver, Gary H. Lyman	239
18	Pathologic analysis of sentinel and nonsentinel lymph nodes in breast carcinoma 2000 ·Cancer ·Donald L. Weaver, David N. Krag, Takamaru Ashikaga, Seth P. Harlow, Maureen O’Connell	4
19	Pathologic analysis of sentinel and nonsentinel lymph nodes in breast carcinoma 2000 ·Cancer ·Donald L. Weaver, David N. Krag, Takamaru Ashikaga, Seth P. Harlow, Maureen O’Connell	167
20	The National Health Service Corps for the 21st Century 2000 ·Journal of Ambulatory Care Management ·Robert M. Politzer, (unknown), (unknown), (unknown), Donald L. Weaver, (unknown), Marilyn Gaston	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact